WARRANTS	6 Months Ended
Jun. 30, 2026
Equity [Abstract]
WARRANTS	NOTE 11 – WARRANTS The Company issued warrants in October 2025 in connection with the issuance of Intermediate Class A Units (see Note 13 – Noncontrolling Interests for additional information). The warrants were classified as liabilities in accordance with ASC 480, Distinguishing Liabilities from Equity (“ASC 480”), and were measured at fair value, with changes in fair value recognized in earnings each reporting period. On April 28, 2026, Centaurus Capital LP (“Centaurus”) delivered a notice to exercise the warrants in full. In accordance with its terms, the warrants were exercised on May 13, 2026 into 3,550,329 shares of Series E-2 redeemable convertible preferred stock, which were immediately converted into 2,554,107 shares of Class A common stock after taking into consideration the Reverse Stock Split. Centaurus paid an aggregate exercise price of $18.7 million in cash and surrendered the original warrants upon full exercise. As a result of this transaction, the warrants are no longer outstanding, and no further shares are issuable thereunder. The Company recognized a loss of $26.9 million and $40.0 million during the three and six months ended June 30, 2026, respectively, related to the remeasurement of the warrants, which is reflected within Other non-operating expense, net in the Condensed Consolidated Statements of Operations. Upon exercise, the warrant liability was derecognized and the Class A common stock issued was recognized in equity.

The Company issued warrants in October 2025 in connection with the issuance of Intermediate Class A Units (see Note 13 – Noncontrolling Interests for additional information). The warrants were classified as liabilities in accordance with ASC 480, Distinguishing Liabilities from Equity (“ASC 480”), and were measured at fair value, with changes in fair value recognized in earnings each reporting period.

On April 28, 2026, Centaurus Capital LP (“Centaurus”) delivered a notice to exercise the warrants in full. In accordance with its terms, the warrants were exercised on May 13, 2026 into 3,550,329 shares of Series E-2 redeemable convertible preferred stock, which were immediately converted into 2,554,107 shares of Class A common stock after taking into consideration the Reverse Stock Split. Centaurus paid an aggregate exercise price of $18.7 million in cash and surrendered the original warrants upon full exercise. As a result of this transaction, the warrants are no longer outstanding, and no further shares are issuable thereunder.

The Company recognized a loss of $26.9 million and $40.0 million during the three and six months ended June 30, 2026, respectively, related to the remeasurement of the warrants, which is reflected within Other non-operating expense, net in the Condensed Consolidated Statements of Operations. Upon exercise, the warrant liability was derecognized and the Class A common stock issued was recognized in equity.